| Literature DB >> 28220068 |
Andrea Katzorke1, Julia B M Zeller1, Laura D Müller1, Martin Lauer1, Thomas Polak1, Andreas Reif2, Jürgen Deckert1, Martin J Herrmann1.
Abstract
Apolipoprotein-E4 (APOE-E4) is a major genetic risk factor for developing Alzheimer's disease (AD). The verbal fluency task (VFT), especially the subtask category fluency, has shown to provide a good discrimination between cognitively normal controls and subjects with AD. Interestingly, APOE-E4 seems to have no effect on the behavioral performance during a VFT in healthy elderly. Thus, the purpose of the present study was to reveal possible compensation mechanisms by investigating the effect of APOE-E4 on the hemodynamic response in non-demented elderly during a VFT by using functional near-infrared spectroscopy (fNIRS). We compared performance and hemodynamic response of high risk APOE-E4/E4, -E3/E4 carriers with neutral APOE-E3/E3 non-demented subjects (N = 288; 70-77 years). No difference in performance was found. APOE-E4/E4, -E3/E4 carriers had a decreased hemodynamic response in the right inferior frontal junction (IFJ) with a corresponding higher response in the left middle frontal gyrus (MFG) during category fluency. Performance was correlated with the hemodynamic response in the MFG. We assume a compensation of decreased IFJ brain activation by utilizing the MFG during category fluency and thus resulting in no behavioral differences between APOE-groups during the performance of a VFT.Entities:
Keywords: Alzheimer’s disease; apolipoprotein-E4; elderly; near-infrared spectroscopy; verbal fluency task
Year: 2017 PMID: 28220068 PMCID: PMC5292419 DOI: 10.3389/fnhum.2017.00046
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
Figure 1Course of exclusion for data analysis. VFT, verbal fluency task; MCI, mild cognitive impairment; APOE4, Apolipoprotein-E4; fNIRS, functional near-infrared spectroscopy; BDI, Beck’s Depresson Inventory-II; GDS, geriatric depression screening scale; MMST, Mini-Mental-Status-Test; DemTect, dementia detecting screening test; 1some subjects were excluded due to more than one reason.
Sample characterization.
| E3/E3 ( | E4/E4, E3/E4 ( | ||||||
|---|---|---|---|---|---|---|---|
| Age | 73.89 | 1.55 | 73.67 | 1.62 | 1.08 | 286 | 0.282 |
| Education (years) | 10.88 | 3.60 | 11.05 | 3.88 | −0.34 | 284 | 0.733 |
| DemTect | 16.35 | 1.87 | 16.09 | 2.40 | 0.87 | 113.6a | 0.384 |
| MMST | 29.20 | 0.97 | 29.37 | 0.88 | −1.40 | 286 | 0.161 |
| BDI-2 | 5.49 | 4.38 | 5.29 | 4.13 | 0.34 | 286 | 0.733 |
| GDS | 1.04 | 1.23 | 1.06 | 1.38 | −0.13 | 286 | 0.900 |
| B-ADL | 1.39 | 0.51 | 1.43 | 0.56 | −0.59 | 286 | 0.553 |
Note: .
Figure 2(Aa) Letter [O2Hb], (b) Category [O2Hb], (c) Letter [HHb], (d) Category [HHb]; (B) Numerical labeling of projected fNIRS and defined ROI based on the activation pattern found; (C) mean hemodynamic response of the active tasks (left: letter VFT; right: category VFT) minus the control condition (weekdays) for all subjects over the ROI as shown in (B); baseline [10 s], task [30 s], post-measurement [20 s]; positive values imply an increased hemodynamic response during task performance compared to the control condition regarding [O2Hb]; for [HHb] negative values imply an increased hemodynamic response during task performance compared to the control condition; non-significant channels are characterized by t-value of 0, presented in a green color; SE, standard error.
Figure 3Significant group difference of risk allele carriers (.